1. Home
  2. BLRX vs BNRG Comparison

BLRX vs BNRG Comparison

Compare BLRX & BNRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLRX
  • BNRG
  • Stock Information
  • Founded
  • BLRX 2003
  • BNRG 2012
  • Country
  • BLRX Israel
  • BNRG Israel
  • Employees
  • BLRX N/A
  • BNRG N/A
  • Industry
  • BLRX Biotechnology: Pharmaceutical Preparations
  • BNRG
  • Sector
  • BLRX Health Care
  • BNRG
  • Exchange
  • BLRX Nasdaq
  • BNRG Nasdaq
  • Market Cap
  • BLRX 17.3M
  • BNRG 14.7M
  • IPO Year
  • BLRX 2011
  • BNRG 2022
  • Fundamental
  • Price
  • BLRX $3.59
  • BNRG $1.45
  • Analyst Decision
  • BLRX Strong Buy
  • BNRG
  • Analyst Count
  • BLRX 2
  • BNRG 0
  • Target Price
  • BLRX $220.00
  • BNRG N/A
  • AVG Volume (30 Days)
  • BLRX 154.8K
  • BNRG 396.4K
  • Earning Date
  • BLRX 03-25-2025
  • BNRG 03-03-2025
  • Dividend Yield
  • BLRX N/A
  • BNRG N/A
  • EPS Growth
  • BLRX N/A
  • BNRG N/A
  • EPS
  • BLRX N/A
  • BNRG N/A
  • Revenue
  • BLRX $21,991,000.00
  • BNRG $41,000.00
  • Revenue This Year
  • BLRX N/A
  • BNRG N/A
  • Revenue Next Year
  • BLRX N/A
  • BNRG N/A
  • P/E Ratio
  • BLRX N/A
  • BNRG N/A
  • Revenue Growth
  • BLRX N/A
  • BNRG N/A
  • 52 Week Low
  • BLRX $3.20
  • BNRG $0.60
  • 52 Week High
  • BLRX $57.60
  • BNRG $4.11
  • Technical
  • Relative Strength Index (RSI)
  • BLRX 36.94
  • BNRG 51.50
  • Support Level
  • BLRX $3.26
  • BNRG $1.02
  • Resistance Level
  • BLRX $4.17
  • BNRG $1.43
  • Average True Range (ATR)
  • BLRX 0.28
  • BNRG 0.18
  • MACD
  • BLRX 0.24
  • BNRG 0.01
  • Stochastic Oscillator
  • BLRX 36.26
  • BNRG 63.24

About BLRX BioLineRx Ltd.

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.

About BNRG Brenmiller Energy Ltd

Brenmiller Energy Ltd is an Israel-based company. It is a technology company that develops, produces, markets, and sells thermal energy storage. The technology of the company allows electrification and decarbonization of the industrial industry sector for integration with renewable energy sources and further reduction of carbon emissions.

Share on Social Networks: